185 related articles for article (PubMed ID: 31050821)
1. Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light.
Faddy HM; Fryk JJ; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC
Transfusion; 2019 Jul; 59(7):2223-2227. PubMed ID: 31050821
[TBL] [Abstract][Full Text] [Related]
2. Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light.
Fryk JJ; Marks DC; Hobson-Peters J; Watterson D; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Faddy HM
Transfusion; 2017 Nov; 57(11):2677-2682. PubMed ID: 28718518
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of Japanese encephalitis virus in plasma by methylene blue combined with visible light and in platelet concentrates by ultraviolet C light.
Rustanti L; Hobson-Peters J; Colmant AMG; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC; Faddy HM
Transfusion; 2020 Nov; 60(11):2655-2660. PubMed ID: 32830340
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of SARS-CoV-2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light.
Hobson-Peters J; Amarilla AA; Rustanti L; Marks DC; Roulis E; Khromykh AA; Modhiran N; Watterson D; Reichenberg S; Tolksdorf F; Sumian C; Seltsam A; Gravemann U; Faddy HM
Transfusion; 2023 Feb; 63(2):288-293. PubMed ID: 36573801
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively.
Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
Transfusion; 2018 Sep; 58(9):2202-2207. PubMed ID: 29732571
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light.
Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
Vox Sang; 2020 Apr; 115(3):146-151. PubMed ID: 31930543
[TBL] [Abstract][Full Text] [Related]
7. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.
Steinmann E; Gravemann U; Friesland M; Doerrbecker J; Müller TH; Pietschmann T; Seltsam A
Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen-reduction technology.
Girard YA; Santa Maria F; Lanteri MC
Transfusion; 2020 Mar; 60(3):622-627. PubMed ID: 31957887
[TBL] [Abstract][Full Text] [Related]
9. Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light.
Fryk JJ; Marks DC; Hobson-Peters J; Prow NA; Watterson D; Hall RA; Young PR; Reichenberg S; Sumian C; Faddy HM
Transfusion; 2016 Sep; 56(9):2278-85. PubMed ID: 27456861
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis E virus is effectively inactivated in platelet concentrates by ultraviolet C light.
Praditya D; Friesland M; Gravemann U; Handke W; Todt D; Behrendt P; Müller TH; Steinmann E; Seltsam A
Vox Sang; 2020 Oct; 115(7):555-561. PubMed ID: 32383163
[TBL] [Abstract][Full Text] [Related]
11. Ultraviolet C light efficiently inactivates nonenveloped hepatitis A virus and feline calicivirus in platelet concentrates.
Gravemann U; Handke W; Lambrecht B; Schmidt JP; Müller TH; Seltsam A
Transfusion; 2018 Nov; 58(11):2669-2674. PubMed ID: 30267410
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light.
Faddy HM; Fryk JJ; Prow NA; Watterson D; Young PR; Hall RA; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC
Transfusion; 2016 Jun; 56(6 Pt 2):1548-55. PubMed ID: 26926832
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis E virus is effectively inactivated by methylene blue plus light treatment.
Gravemann U; Engelmann M; Kinast V; Burkard T; Behrendt P; Schulze TJ; Todt D; Steinmann E
Transfusion; 2022 Nov; 62(11):2200-2204. PubMed ID: 36125237
[TBL] [Abstract][Full Text] [Related]
14. Challenge study of the pathogen reduction capacity of the THERAFLEX MB-Plasma technology.
Reichenberg S; Gravemann U; Sumian C; Seltsam A
Vox Sang; 2015 Aug; 109(2):129-37. PubMed ID: 25899343
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of the THERAFLEX UV-Platelets pathogen inactivation system - an update.
Seghatchian J; Tolksdorf F
Transfus Apher Sci; 2012 Apr; 46(2):221-9. PubMed ID: 22365926
[TBL] [Abstract][Full Text] [Related]
16. Amotosalen and ultraviolet A light efficiently inactivate MERS-coronavirus in human platelet concentrates.
Hashem AM; Hassan AM; Tolah AM; Alsaadi MA; Abunada Q; Damanhouri GA; El-Kafrawy SA; Picard-Maureau M; Azhar EI; Hindawi SI
Transfus Med; 2019 Dec; 29(6):434-441. PubMed ID: 31696565
[TBL] [Abstract][Full Text] [Related]
17. Bacterial inactivation of platelet concentrates with the THERAFLEX UV-Platelets pathogen inactivation system.
Gravemann U; Handke W; Müller TH; Seltsam A
Transfusion; 2019 Apr; 59(4):1324-1332. PubMed ID: 30588633
[TBL] [Abstract][Full Text] [Related]
18. Proteome changes in platelets after pathogen inactivation--an interlaboratory consensus.
Prudent M; D'Alessandro A; Cazenave JP; Devine DV; Gachet C; Greinacher A; Lion N; Schubert P; Steil L; Thiele T; Tissot JD; Völker U; Zolla L
Transfus Med Rev; 2014 Apr; 28(2):72-83. PubMed ID: 24685438
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of Zika virus in platelet components using amotosalen and ultraviolet A illumination.
Santa Maria F; Laughhunn A; Lanteri MC; Aubry M; Musso D; Stassinopoulos A
Transfusion; 2017 Aug; 57(8):2016-2025. PubMed ID: 28671343
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of chikungunya virus in blood components treated with amotosalen/ultraviolet A light or amustaline/glutathione.
Laughhunn A; Huang YS; Vanlandingham DL; Lanteri MC; Stassinopoulos A
Transfusion; 2018 Mar; 58(3):748-757. PubMed ID: 29322519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
